SEC
SHC icon

Seven Eight Capital’s Sotera Health SHC Stock Holding History

Seven Eight Capital’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,752
Closed -$230K – 533
2024
Q3 		$230K Buy
+13,752
New +$201K 0.02% 670

Other funds holding SHC

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
MC
MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

Seven Eight Capital's SHC Position: Q4 2024 in Review

Seven Eight Capital sold out of Sotera Health (SHC) in Q4 2024, closing a stake of 13,752 shares — an estimated $230K sold.

Seven Eight Capital first reported a position in SHC in Q3 2024 and held it in 1 quarter. The position peaked at $230K in Q3 2024. 216 funds tracked by Wall St. Rank hold SHC as of Q4 2024.

  • Seven Eight Capital reported no remaining Sotera Health position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 13,752 Sotera Health shares in Q4 2024, an estimated $230K.
  • Seven Eight Capital first reported a position in Sotera Health in Q3 2024 and held it in 1 quarter.
  • Seven Eight Capital's Sotera Health position peaked at $230K in Q3 2024.
  • 216 funds tracked by Wall St. Rank held Sotera Health as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.